Dissecting the Bergman cycloaromatization kinetics for ortho-substituted benzannelated enediynes

ORGN 682

Tarek A. Zeidan, t-zeidan@northwestern.edu1, Serguei V. Kovalenko, kovalenko@chem.fsu.edu2, Mariappan Manoharan2, and Igor V. Alabugin, alabugin@chem.fsu.edu2. (1) Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, (2) Department of Chemistry and Biochemistry, Florida State University, Dittmer Chemistry Building, Tallahassee, FL 32306-4390
Natural occurring enediyne antibiotics such as calicheamicin, esperamicin, dynemicin and neocarzinostatin, undergo Bergman cycloaromatization as the key step in their biological activity. Once activated, the enediyne moiety is transformed into a highly reactive intermediate, 1,4-dihydrobenzene (p-benzyne). This intermediate abstracts two hydrogen atoms, one from the sugar backbone of each DNA strand, eventually leading to the self-programmed cell death (apoptosis). Unfortunately, these anticancer drugs are highly toxic due to the lack of selectivity towards cancerous cells. En route for developing more selective enediynes, our group has initiated a new approach that involves controlling the rate of the Bergman cyclization through introduction of substituents spatially close to the enediyne moiety. DFT computations showed that nature of ortho-substituents in benzannelated enediynes can alter the activation energy barrier of the cyclization. We will report experimental determination of rate constants and activation energies for the Bergman cyclization of a set of ortho-substituted enediynes chosen by computational predictions. Changing in the concentration of hydrogen-atom donor, 1,4-cyclohexadiene (1,4-CHD), change the overall apparent rate constant (kapp), thus, enabling us to determine the rate constants for every step of the Bergman cycloaromatization process.